CSR1	YLR380W	phosphatidylinositol transporter activity	cell wall organization and biogenesis*	cytoplasm		chs5 spa2 rescue; isolated as a multicopy suppressor of the lethality of chs5 spa2 double mutant at		Null mutant is viable
PDR16	YNL231C	phosphatidylinositol transporter activity	response to drug*	cytoplasm	YGL014W	YHR007C	YNL192W		involved in pleiotropic drug resistance by controlling lipids in various cellular compartments; posi	Pdr17p homolog|Sec14p homolog	Null mutant is viable, exhibits hypersensitivity to azole inhibitors of ergosterol biosynthesis, alt
PDR17	YNL264C	phosphatidylinositol transporter activity	response to drug*	cytoplasm	YNL098C	YLR113W	YDR126W		involved in pleiotropic drug resistance by controlling lipids in various cellular compartments; puta	Pdr16p homolog|Sec14p homolog	Null mutant is viable, exhibits no observable phenotypes; pdr16 pdr17 double deletion mutants exhibi
SEC14	YMR079W	phosphatidylinositol transporter activity	Golgi to plasma membrane transport*	cytosol	YDL001W		Required for vesicle budding from the Golgi	phosphatidylinositol transfer protein	Null mutant is inviable; other mutations are temperature sensitive
SFH5	YJL145W	phosphatidylinositol transporter activity	phospholipid transport	cellular_component unknown		putative phosphatidylinositol transfer protein	Sec14p homolog	
